Balaxi Pharmaceuticals Ltd. - Research Center
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
41.59 |
54.72 |
38.60 |
62.69 |
43.36 |
Operating profit |
4.68 |
7.76 |
6.83 |
10.23 |
10.03 |
Interest |
0.62 |
0.22 |
0.04 |
0.02 |
- |
Gross profit |
5.34 |
12.62 |
8.31 |
11.44 |
12.02 |
EPS (Rs) |
0.73 |
1.86 |
1.20 |
1.69 |
1.79 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
1.28 |
5.08 |
1.52 |
1.22 |
1.99 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
32.76 |
42.11 |
27.92 |
49.00 |
31.52 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
2.51 |
2.29 |
1.59 |
1.29 |
0.88 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
1.63 |
2.56 |
2.26 |
2.17 |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
- |
- |
- |
- |
0.93 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.26 |
0.16 |
0.16 |
0.09 |
0.04 |
Taxation |
1.34 |
3.14 |
2.15 |
2.88 |
3.01 |
Net profit / loss |
3.74 |
9.31 |
6.00 |
8.47 |
8.97 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.23 |
10.00 |
10.00 |
10.00 |
10.00 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
11.26 |
14.19 |
17.69 |
16.32 |
23.13 |
GPM (%) |
12.46 |
21.10 |
20.71 |
17.90 |
26.50 |
NPM (%) |
8.72 |
15.57 |
14.95 |
13.25 |
19.78 |